Drug Topics addressed the summer slowdown in pharmacy this week, and the framing they used deserves to travel further than a podcast episode. The stretch of July and August is not a gap to endure. It is the only stretch of the year when a pharmacist has real margin to build something. And the pharmacists who use it deliberately come out of September materially ahead of where they went in.
Why the Lull Is Real and Why That Makes It Valuable
Prescription volume does dip in summer. Patient traffic eases. The urgent pace of the fall and winter immunization season, the holiday medication refill surge, and the post-New Year chronic disease management rush are months away. Most pharmacists respond to this by coasting until September.
The most forward-thinking pharmacists respond by recognizing that this window is structurally rare. The busiest pharmacists in the country, managing high-volume dispensing, complex prior authorizations, staff shortages, and constant patient flow, rarely have time to step back and invest in the infrastructure that determines where their career and practice will be in five years. Summer is that time, the only reliable window the pharmacy calendar provides.
A credential earned in August changes what you’re worth in October. A physician relationship built in July generates referrals in September. A clinical protocol documented in August gets launched in November. A CLIA waiver submitted in July clears state review by October. The summer doesn’t slow down your career unless you let it.
The Credential Window: Which Certifications Make Sense Right Now
The compensation data from the June Drug Channels analysis, covered in a prior issue of this newsletter, established the financial case for specialty credentialing with unusual clarity: the average senior retail pharmacist earns less than the average mid-career hospital clinical pharmacist, and the credential is what opens the door to the higher-compensated setting.
The summer certification window is the specific moment when that investment becomes actionable. BPS board certification exams are offered twice annually, with fall testing windows typically in October and November for several specialty designations. Applications for fall testing open in August. That means the pharmacist who sits down this week, identifies the certification most aligned with their patient population’s fastest-growing needs, and submits their application by mid-August is positioned to sit for the exam this fall.
The five highest-leverage certifications for the clinical opportunities this newsletter has documented across 2026: BCACP for ambulatory care and the CKM syndrome patient population that value-based care payers are actively building programs around. CDCES for the diabetes management and ADA 2026 Standards role that explicitly calls for pharmacist involvement in cardiorenal care. BCOP for precision oncology and the molecular tumor board participation that the mRNA cancer vaccine era is creating new demand for. BCPS for hospital and health-system clinical roles, where the 7.4% vacancy rate for specialized positions makes credentialed applicants the ones receiving offers. BCPP for psychiatric medication management and the CMS deprescribing billing pathway that HHS announced in May.
All five have documented demand gaps. All five open practice settings that pay more than most current retail-level compensation. And all five have a BPS application window that opens this summer.
The Service Line Window: What to Build Before Fall Volume Returns
The second highest-leverage use of summer hours is building the clinical protocol documentation for a new service line that will be launch-ready when fall patient volume returns.
This newsletter has documented five specific clinical service models with sufficient evidence and operational infrastructure to launch in a community or health-system pharmacy setting right now: Remote Patient Monitoring for hypertension and diabetes, with live CPT billing codes and documented outcomes showing 74% blood pressure control rates at Geisinger. Diabetic retinopathy AI screening, with CPT 92229 Medicare reimbursement and the McKesson-APhA-AAO pilot now selecting pharmacy partners. MASLD screening using FIB-4 calculation, requiring only existing lab data and a 30-second calculation. Pharmacogenomics consultation, with CPIC guidelines covering 160 drugs and 34 genes and direct billing pathways through collaborative practice agreements. GLP-1 comprehensive management protocols covering the full cascade from Wegovy HD dysesthesia to oral semaglutide SNAC counseling to the new Medicare GLP-1 Bridge eligibility determination workflow.
Building the clinical protocol documentation for any one of these requires time and focused attention, not budget. The protocol document covers patient eligibility criteria, the clinical workflow from intake to documentation, the billing code and payer requirements, the staff training requirements, and the outcome metrics that will be tracked. A completed protocol document is what separates a clinical idea from a launchable service.
The pharmacist who completes that protocol documentation for one service during August will walk into September with a service ready to pilot. The one who doesn’t will still be planning to build it next spring.
The Physician Relationship Window: The Referral Pipeline That Pays for Years
The clinical services that generate the highest revenue for community and specialty pharmacies depend on a referral relationship infrastructure that most pharmacists have been meaning to build for months or years. The summer is when that work can happen.
Physician offices are slightly less frenetic in summer. Scheduling a 20-minute introduction meeting with a primary care practice, an endocrinology group, an oncology practice, or a cardiology office is meaningfully easier in July than in October. And the relationship built in that meeting generates referrals for GLP-1 coaching, CGM training, pharmacogenomics consultation, or the access model coordination work this newsletter covered in the CMS ACCESS Model issue for months and years after the meeting ends.
The script for that meeting has never been simpler after a year of this newsletter’s coverage. “I wanted to introduce our pharmacy’s clinical services and explore whether we could support your patients more systematically. Based on the ADA 2026 Standards, your diabetic patients who are not hitting their cardiorenal targets would benefit from pharmacist-led medication optimization, and we have the infrastructure to bill for those services under your ACO’s quality metrics. Can I walk you through what that would look like?” That conversation, built on the clinical language documented in this newsletter’s ADA, CKM, ACCESS Model, and value-based care coverage, gets meetings. Meetings get referrals. Referrals build panels.
Five physician office visits in July, properly followed up, could generate a steady referral stream for clinical services by October. The pharmacist who makes those visits in July is not doing extra work. They are doing the business development that the fall season will be too busy to accommodate.
The CLIA Window: The Certification That Unlocks Point-of-Care Billing
If your pharmacy does not yet hold a CLIA certificate of waiver, the summer is the single best time to submit the application.
CLIA waiver certification is required for pharmacies that want to offer point-of-care testing services: A1c, lipid panels, glucose, flu, strep, COVID-19, and, as documented in the diabetic retinopathy screening issue, AI-based retinal imaging with CPT 92229. Without CLIA certification, these services cannot be billed to Medicare, Medicaid, or most commercial payers.
The application process is not complex. The CMS Form 116, Clinical Laboratory Improvement Amendments (CLIA) Application for Certification, is available at cms.gov and requires submitting the pharmacy’s NPI, physical address, test categories, and laboratory director information. Processing times vary by state, typically six to twelve weeks. A pharmacy that submits in August is in position for full CLIA-waived testing by October or November, exactly when fall immunization programs, respiratory illness testing, and post-summer chronic disease check-ins generate the highest point-of-care testing demand.
The CLIA waiver annual fee is $180. The CPT codes it unlocks, including CPT 99453 through 99458 for RPM and CPT 92229 for retinal screening alongside the standard point-of-care testing panels, generate thousands of dollars annually per enrolled patient at full panel volume. This is the highest-ROI regulatory investment available to most community pharmacies that don’t yet hold the certification.
The Documentation Window: The Practice Infrastructure That Gets Neglected Year Round
Every pharmacist reading this newsletter has a list of practice infrastructure tasks that have been on the to-do list for months: the standing order update that needs to be renegotiated with the collaborating physician. The prior authorization template library that would save 30 minutes per case but never gets built because the queue is always full. The patient counseling scripts for new service areas that get improvised instead of documented. The quality metric tracking spreadsheet that exists in someone’s head but not in a shared system.
These tasks require a specific kind of time: not necessarily long stretches, but uninterrupted thinking time without a patient at the counter, a phone ringing, or a technician asking a question. The summer counter pace provides that time if it is defended.
The pharmacist who blocks two protected hours this week, identifies the single infrastructure gap that costs the most time and consistency throughout the year, and closes that gap before August ends comes into September operating more efficiently than before. The efficiency compounds. Every week that prior authorization template saves 30 minutes is 30 minutes the pharmacist can redirect toward a billable clinical encounter.
Your Specific Action Before This Weekend
Block two hours on your calendar before Friday. Not a meeting, not a shift overlap, actual protected calendar time with a closed door or a turned phone.
During those two hours, write down the single most important clinical or business investment you’ve been meaning to make in your practice for the past six months. Then identify the first concrete step that moves it forward. Not the whole project. Not the roadmap. One step.
Is it submitting a CLIA waiver application? Download Form 116 and complete the first two pages. Is it building an RPM enrollment protocol? Write the patient eligibility criteria and the first five steps of the clinical workflow. Is it scheduling physician office visits for referral development? Draft the email you’ll send requesting a 20-minute introduction meeting and send it to three offices. Is it submitting a BPS certification application? Log into bpsweb.org and confirm your eligibility and the fall testing window dates.
The pharmacists who come out of summer stronger treated the lull as a runway, not a rest stop. Two hours. One concrete step. Before the weekend.
Sources: Drug Topics (Pharmacy Unlocked Podcast: Pharmacists and the Summer Slowdown, July 2026), Board of Pharmacy Specialties (BPS Certification Exam Windows, Application Deadlines, bpsweb.org), CMS (CLIA Application for Certificate of Waiver, Form CMS-116, cms.gov), CMS (CLIA Fee Schedule 2026), APhA Foundation and American Academy of Ophthalmology (McKesson Diabetic Retinopathy Pilot Partner Selection), Drug Channels (Pharmacist Salaries and Employment in 2025: Retail Declines, Hospital Gains, June 2026), Pharmacy Times (McKesson ideaShare 2026: Recapping Key Insights from Denver, June 2026)